Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic‐phase chronic myeloid leukemia

Cancer, EarlyView.


from Cancer via ola Kala on Inoreader https://ift.tt/2rpy8ZJ
via IFTTT